Document:

Exhibit

Exhibit 10.1

TRINITY INDUSTRIES, INC.

FOURTH AMENDED AND RESTATED TRINITY INDUSTRIES, INC.
2004 STOCK OPTION AND INCENTIVE PLAN

NOTICE OF GRANT OF STOCK OPTIONS

TO:        (the “Optionee” or “you”)

FROM:        Trinity Industries, Inc., a Delaware corporation (the “Company”)

You have been granted a Stock Option to purchase Shares of the Company pursuant to the Fourth Amended and Restated Trinity Industries, Inc. 2004 Stock Option and Incentive Plan (the “Plan”).  This Stock Option is subject to all of the terms and conditions set forth in this Notice of Grant of Stock Options (the “Notice of Grant”), the Plan, and the Non-Qualified Stock Option Agreement attached hereto as Exhibit A (the “Agreement”), each of which are incorporated into this Notice of Grant.  Capitalized terms that are not defined in the Notice of Grant shall have the meanings given to them in the Agreement, and if not defined in the Agreement, the meanings given to them in the Plan.  

Date of Grant:                    

Option Number:                

Number of Shares subject to the Stock                    
Option (the “Optioned Shares”):        

Option Price (per Optioned Share):        

Total Option Price:                

Type of Stock Option:                        

Expiration Date:    

Vesting and Exercisability:    

Except as specifically provided in the Agreement and subject to certain restrictions and conditions set forth in the Plan, the Stock Option shall become vested and exercisable in accordance with the following table, provided you are employed by or otherwise providing continuous services to the Company or an Affiliate from the Date of Grant through the vesting date set forth below (the “Vesting Date”):

	
		
	Stock Option Vested
	Vesting Date

	 
	 

Additional Terms/Acknowledgment:  You acknowledge and agree that the Notice of Grant and the vesting and exercisability schedule set forth herein do not constitute an express or implied promise of your continued employment or engagement for the vesting period, for any period, or at all, and shall not interfere with your right or the Company’s right to terminate your employment or service relationship with the Company or its Affiliates at any time, with or without Cause.  You further acknowledge and agree that nothing in this Notice of Grant, the Agreement or the Plan shall confer upon you the right to receive any future Awards.  

Committee Decisions/Interpretations/Acceptance:  You hereby agree to accept as binding, conclusive and final all decisions or interpretations of the Human Resources Committee of the Board (the “Committee”) upon any questions relating to the Plan, the Agreement, and this Notice of Grant.  By accepting this Notice of Grant, you acknowledge receiving a copy of the Plan and the Agreement, and represent that you are familiar with the terms and provisions thereof, and hereby accept the Stock Option subject to all of the terms and provisions hereof and thereof.  You further acknowledge and represent that you have reviewed this Notice of Grant, the Plan, and the Agreement in their entirety, have had an opportunity to obtain the advice of counsel prior to executing this Notice of Grant, and fully understand all of the provisions of this Notice of Grant, the Plan and the Agreement.

* * * * * * *

By your signature below, you agree that the Notice of Grant, the Agreement, and the Plan, constitute your entire agreement with respect to the Stock Option, and except as set forth therein, may not be modified except by means of a writing signed by the Company and you.  This Notice of Grant and Agreement may be executed in duplicate counterparts, the production of either of which (including a signature or proof of electronic acceptance) shall be sufficient for all purposes for the proof of the binding terms of this Stock Option.

THE COMPANY:

	
		
	Trinity Industries, Inc.

	 
	 

	By:
	/s/ Melendy Lovett

	Name:
	Melendy Lovett

	Title:
	Senior Vice President and Chief Financial Officer

                
OPTIONEE:

                                                        
                                                    
Signature

Name:                        

Date:                            

Exhibit A
FOURTH AMENDED AND RESTATED TRINITY INDUSTRIES, INC.
2004 STOCK OPTION AND INCENTIVE PLAN

NON-QUALIFIED STOCK OPTION AGREEMENT

1.Grant of Option.  Trinity Industries, Inc., a Delaware corporation (the “Company”) hereby grants to the Optionee named on the Notice of Grant (the “Optionee”), a Stock Option to purchase up to the total number of Optioned Shares subject to the Stock Option as set forth in the Notice of Grant, at the Option Price as set forth in the Notice of Grant, subject to the terms and conditions set forth in this Non-qualified Stock Option Agreement (this “Agreement”) and the Fourth Amended and Restated Trinity Industries, Inc. 2004 Stock Option and Incentive Plan, as amended from time to time (the “Plan”).  The Option Price is equal to or greater than the Fair Market Value per Share on the Date of Grant set forth in the Notice of Grant.  The “Option Period” shall commence on the Date of Grant and shall expire on the Expiration Date set forth on the Notice of Grant, unless terminated earlier in accordance with Section 4 below.  The Stock Option is a Non-qualified Stock Option that is intended to comply with the provisions governing nonqualified stock options under the final Treasury Regulations issued on April 17, 2007, in order to exempt this Stock Option from application of Section 409A of the Code.

2.Subject to Plan.  The Stock Option and its exercise are subject to the terms and conditions of the Plan, and in the event of conflict between the Notice of Grant, this Agreement and the Plan, the terms, conditions and provisions of the Plan shall be controlling.  Unless otherwise defined herein, the capitalized terms used herein shall have the meanings given to them in the Notice of Grant, and if not defined in the Notice of Grant, the meanings given to them in the Plan.  The Stock Option is subject to any rules promulgated pursuant to the Plan by the Board or the Committee, as applicable, and communicated to the Optionee in writing.  

3.Vesting of Stock Option; Time of Exercise.  
a.    Except as specifically provided in this Agreement and subject to certain restrictions and conditions set forth in the Plan, the Stock Option shall vest and become exercisable as provided in the Notice of Grant.  Once vested, the Stock Option may be exercised, in whole or in part, at any time during the Option Period.  The vesting schedule set forth in the Notice of Grant may be accelerated at the discretion of the Committee as provided in the Plan or in the event the provisions of paragraph (b) of this Section 3 apply.
b.    If the Optionee ceases to be an officer, director, or employee of the Company or an Affiliate by reason of death, Disability, or Retirement, to the extent not previously vested, the Stock Option shall become fully vested and the Optionee or the Optionee’s personal representatives, heirs, legatees, or distributees, as appropriate, shall have the immediate right to fully exercise the Stock Option at any time during the Option Period.
4.Term; Forfeiture.  Except as otherwise provided in this Agreement, to the extent the Stock Option is not vested on the date the Optionee ceases to be an officer, director, or employee of the Company or an Affiliate (a “Termination of Service”) for any reason, such unvested portion of the Stock Option shall be terminated and forfeited on that date.  Except as otherwise provided in this Agreement, the vested portion of the Stock Option shall be terminated and forfeited and the Option Period shall end upon the earliest occurrence of (i) the Expiration Date, or (ii) the first of the following to occur:

a.    Unless otherwise determined by the Committee, if the Optionee incurs a Termination of Service by reason of the fact that the Optionee is discharged by the Company or an Affiliate for Cause (as defined below), as determined solely and exclusively by the Committee, then upon such Termination of Service the Stock Option shall be terminated and forfeited and the Option 

Period shall end.  For purposes of this Agreement, the term “Cause” shall have the meaning given to such term in the CIC Agreement (as defined below); provided, however, if such agreement does not define the term “Cause” or there is no such Agreement, then the term “Cause” shall mean (i) the willful and continued failure by the Optionee to substantially perform the Optionee’s duties with the Company (other than any such failure resulting from the Optionee’s incapacity due to physical or mental illness and other than in respect of any duties inconsistent with, or more burdensome than, the Optionee’s duties with the Company immediately prior to a Change in Control of the Company); (ii) misappropriation or embezzlement from the Company or any other act or acts of dishonesty by the Optionee constituting a felony that results, or is intended to result, directly or indirectly, in gain to or personal enrichment of the Optionee at the Company’s expense; (iii) the conviction of the Optionee of a felony involving the moral turpitude of the Optionee; or (iv) the willful engagement by the Optionee in continued misconduct which is materially injurious to the Company after having been advised in writing of the particular misconduct deemed by the Company to be materially injurious to the Company and instructed in such writing to cease any further misconduct of a similar nature.  For purposes of the foregoing, no act or failure to act on the part of the Optionee shall be considered “willful” unless done, or omitted to be done, by the Optionee not in good faith and without reasonable belief that the action or omission of the Optionee was in the best interest of the Company.
b.    Unless such periods are otherwise extended by the Committee, if the Optionee incurs a Termination of Service by reason of the Optionee’s Retirement, then the Option Period shall end thirty-six (36) months after the date of such Termination of Service at which time the Stock Option shall be terminated and forfeited; provided, however, that if the Optionee dies during such thirty-six (36) month period, then the Option Period shall end twelve (12) months after the date of the Optionee’s death at which time the Stock Option shall be terminated and forfeited. 
c.    Unless such periods are otherwise extended by the Committee, if the Optionee incurs a Termination of Service by reason of the Optionee’s Disability, then the Option Period shall end twelve (12) months after the date of the Optionee’s Termination of Service at which time the Stock Option shall be terminated and forfeited.
d.    Unless such periods are otherwise extended by the Committee, if the Optionee incurs a Termination of Service by reason of death, then the Option Period shall end twelve (12) months after the date of the Optionee’s death at which time the Stock Option shall be terminated and forfeited. The Optionee’s personal representatives, heirs, legatees, or distributees, as appropriate, shall have the right to exercise the Stock Option during such twelve (12) month period. 
e.    Unless such periods are otherwise extended by the Committee, if the Optionee incurs a Termination of Service for any reason other than as described in paragraphs (a) through (e) above, then the Option Period shall end three (3) months after the date of the Optionee’s Termination of Service at which time the Stock Option shall be terminated and forfeited; provided, however, that if the Optionee dies during such three (3) month period, then the Option Period shall end twelve (12) months after the date of the Optionee’s death at which time the Stock Option shall be terminated and forfeited.
f.    Notwithstanding the foregoing, subject to paragraph (g) below, if the Optionee and the Company have entered into a Change in Control Agreement, as amended or restated from time to time (a “CIC Agreement”), then the Stock Option shall be exercisable until the later of (i) the last date the Stock Option may be exercised pursuant to paragraphs (b) through (e) above, or (ii) the last date the Stock Option may be exercised pursuant to the terms of the CIC Agreement.
g.    Notwithstanding anything to the contrary in paragraphs (b) through (f) above, no portion of the Stock Option shall be exercisable after the Expiration Date.

5.Who May Exercise.  Subject to the terms and conditions set forth in the Notice of Grant and Sections 3 and 4 above, during the lifetime of the Optionee, the Stock Option may be exercised only by the Optionee, or by the Optionee’s guardian or personal or legal representative.  If the Stock Option is exercisable following the Optionee’s death as specified in Section 4, and the Optionee has not exercised the Stock Option as to the maximum number of vested Optioned Shares as set forth in the Notice of Grant as of the date of death, the following persons may exercise the vested portion of the Stock Option on behalf of the Optionee with respect to the vested Optioned Shares at any time prior to the earliest of the dates specified in Section 4 hereof: the personal representative of his estate or the person(s) who acquired the right to exercise the Stock Option by bequest or inheritance or by reason of the death of the Optionee, provided that the Stock Option shall remain subject to the other terms of the Notice of Grant, this Agreement, the Plan, and all Applicable Laws, rules, and regulations.

6.Manner of Exercise.  Subject to such administrative regulations as the Committee may from time to time adopt, the Stock Option may be exercised by the delivery of written notice to the Committee setting forth the number of Shares with respect to which the Stock Option is to be exercised (the “Exercise Notice”) and the date of exercise thereof (the “Exercise Date”), which shall be the date that the Optionee has delivered both the Exercise Notice and the consideration to the Company with a value equal to the total Option Price of the Shares to be purchased (plus any federal, state or local income tax and employment tax withholding or other tax payment due with respect to such exercise).  The Stock Option may be exercised only with respect to a full Share, and no fractional Share shall be issued.  On the Exercise Date, the Optionee shall deliver to the Company consideration with a value equal to the total Option Price of the shares to be purchased, payable as follows: (a) in cash (including check, bank draft, or money order); (b) by the delivery of Shares (including Restricted Stock when authorized by the Committee) already owned by the Optionee; (c) by directing the Company (when authorized by the Committee) to withhold Shares otherwise issuable upon exercise, having a Fair Market Value equal to the total Option Price; provided that no delivery or withholding of Shares will be permitted if it would result in the Company recognizing additional accounting expense after the grant of the Stock Option or upon its exercise; (d) by providing with the notice of exercise an order to a designated broker to sell part or all of the Shares and to deliver sufficient proceeds to the Company, in cash or by check payable to the Company, to pay the full purchase price of the Shares (i.e., a “cashless exercise”); or (e) any combination of the foregoing. Shares delivered or tendered to exercise the Stock Option must be held for at least six-months prior to the date of exercise of the Stock Option if the Shares were acquired by previous exercise of a Stock Option or by vesting of Restricted Stock or Restricted Stock Units.  Shares acquired by other methods (e.g., open market, purchase, gift, etc.) do not have the six-month holding requirement.  Upon payment of all amounts due from the Optionee, the Company shall cause the issuance of the Shares then being purchased to the Optionee (or the person exercising the Optionee’s Stock Option in the event of the Optionee’s death) as soon as practicable after the Exercise Date, in accordance with Section 10.  

7.Tax Requirements.  Shares shall only be delivered pursuant to the exercise of the Stock Option if the Optionee or the Optionee’s personal representative has made appropriate arrangements with the Company in accordance with Section 27 of the Plan for the payment of applicable taxes which are required to be withheld under federal, state or local law or the tax withholding requirement has otherwise been satisfied.

8.Compliance with Securities and Other Laws.  The obligation of the Company to deliver Shares under the Stock Option shall be subject to the condition that, if at any time the Company shall determine in its discretion that the listing, registration, or qualification of the Stock Option or the Shares upon any securities exchange or inter-dealer quotation system or under any state or federal law, or the consent or approval of any governmental regulatory body, is necessary as a condition of, or in connection with, the Stock Option or the issuance or purchase of Shares thereunder, then the Stock Option may not be exercised in whole or in part unless such listing, registration, qualification, consent, or approval shall have been effected or obtained free of any conditions not reasonably acceptable to the Committee.  The Company shall not be required to sell or issue Shares under Stock Option if the issuance thereof would constitute a violation by either the Optionee or the Company of any provision of any law or regulation of any governmental authority or any securities exchange or inter-dealer quotation system.  As a condition of any sale or issuance of Shares under the Stock Option, the 

Company may place legends on Shares, issue stop transfer orders and require such agreements or undertakings from the Optionee as the Company may deem necessary or advisable to assure compliance with any such law or regulation.  Any determination in this connection by the Company shall be final, binding, and conclusive.  The obligations of the Company and the rights of the Optionee are subject to all applicable laws, rules, and regulations.

9.Nontransferability of Stock Option.  Except as provided in the Plan, the Stock Option is not assignable or transferable by the Optionee except by will or the laws of descent and distribution.  Any attempted assignment, transfer, pledge, hypothecation, or other disposition of the Stock Option contrary to the provisions hereof, or the levy of any execution, attachment, or similar process upon the Stock Option shall be null and void and without effect.

10.Delivery of Shares; Rights as Stockholder.  Shares will be delivered to the Optionee as soon as practical after exercise of the Stock Option; subject to the requirements of Sections 7 and 8.  At the discretion of the Company, Shares may be delivered to the Optionee by book-entry credit to an account established in the Optionee’s name by the Company with the Company’s transfer agent, or upon written request from the Optionee (or the Optionee’s personal representative, beneficiary or estate, as the case may be) in certificates in the Optionee’s name (or, if exercised after the Optionee’s death, in the name of the Optionee’s personal representative, beneficiary or estate). The Optionee shall not acquire or have any rights as a stockholder of the Company, including, but not limited to, the right to vote Optioned Shares or the right to receive dividends on Optioned Shares, until Shares issuable upon exercise of the Option are actually issued and delivered to the Optionee in accordance with this Agreement, at which time the Optionee share acquire the rights as a stockholder of the Company with respect to such issued and delivered shares.  Except as otherwise provided in Section 11 hereof, no adjustment shall be made for dividends or other rights for which the record date is prior to issuance of Shares to the Optionee (or the Optionee’s personal representative, beneficiary or estate, as the case may be).  The Optionee, by his or her execution of this Agreement, agrees to execute any documents requested by the Company in connection with the issuance of Shares.

11.Adjustment upon Changes in Capitalization.  The number of Shares covered by the Stock Option, and the Option Prices thereof, shall be subject to adjustment in accordance with Section 20 of the Plan.  The granting of this Stock Option shall not affect in any way the right or power of the Company to make adjustments, reclassifications, reorganizations, or changes of its capital or business structure or to merge or to consolidate or to dissolve, liquidate, or sell, or transfer all or any part of its business or assets.

12.No Right to Continue Service or Employment.  Nothing in the Notice of Grant, this Agreement or the Plan shall confer upon the Optionee any right to remain an officer or employee of the Company or one of its Subsidiaries, and nothing herein shall be construed in any manner to interfere in any way with the right of the Company or its Subsidiaries to terminate the Optionee’s service at any time.

13.Interpretation by the Committee.  The administration of the Plan has been vested in the Committee, and all questions of interpretation and application of the Notice of Grant and this Agreement shall be subject to determination by a majority of the members of the Committee, which determination shall be final and binding on the Optionee.

14.Restrictive Covenants.

a.    Non-Disclosure.
(i)    During the Optionee’s employment with the Company, the Company shall grant the Optionee otherwise prohibited access to the Company’s trade secrets and confidential information which is not known to the Company’s competitors or within the Company’s industry generally, which was developed by the Company over a long period of time and/or at the Company’s substantial expense, and which is of great competitive value to the Company.  

“Confidential Information” includes all trade secrets, inventions and confidential and proprietary information of the Company including, but not limited to, the following: all documents or information, in whatever form or medium, concerning or relating to any of the Company’s discoveries; designs; plans; strategies; models; processes; techniques; technical improvements; development tools or techniques; modifications; formulas; patterns; devices; data; product information; manufacturing and engineering processes, data and strategies; operations; products; services; business practices; policies; training manuals; principals; vendors and vendor lists; suppliers and supplier lists; customers and potential customers; contractual relationships; research; development; know-how; technical data; software; product construction and product specifications; project information and data; developmental or experimental work; plans for research or future products; improvements; interpretations, and analyses; database schemas or tables; infrastructure; marketing methods; finances and financial information and data; business plans; marketing and sales plans and strategies; budgets; pricing and pricing strategies; costs; customer and client lists and profiles; customer and client nonpublic personal information; business records; audits; management methods and information; reports, recommendations and conclusions; and other business information disclosed or made available to the Optionee by the Company, either directly or indirectly, in writing, orally, or by drawings or observation. “Confidential Information” does not include, and there shall be no obligation hereunder with respect to, information that (A) is generally available to the public on the Date of Grant or (B) becomes generally available to the public other than as a result of a disclosure not otherwise permissible hereunder.  Throughout the Optionee’s employment with the Company and thereafter: (x) the Optionee shall hold all Confidential Information in the strictest confidence, take all reasonable precautions to prevent its inadvertent disclosure to any unauthorized person, and follow all policies of the Company protecting the Confidential Information; and (y) the Optionee shall not, directly or indirectly, utilize, disclose or make available to any other person or entity, any of the Confidential Information, other than in the proper performance of the Optionee’s duties.
(ii)    If the Optionee shares Confidential Information with outside persons, other than as required to comply with applicable laws and as necessary to manage the Optionee’s personal finances or in accordance with the exceptions contained in this Section 14(a), the Optionee may be subject to the Optionee’s rights hereunder being forfeited upon a determination by the Committee that the Optionee has violated this Section 14.  Nothing in this Agreement prohibits the Optionee from reporting possible violations of U.S. federal or state law or regulations to any governmental agency or entity, including but not limited to the Department of Justice, the Securities and Exchange Commission, the Congress, and any agency Inspector General, making other disclosures that are protected under the whistleblower provisions of U.S. federal or state law or regulation, or participating in an investigation or proceeding conducted by any governmental or law enforcement agency or entity.  The Optionee does not need the prior authorization of the Company to make any such reports or disclosures, and the Optionee is not required to notify the Company that the Optionee has made such reports or disclosures.  
(iii)    This Agreement also does not prohibit the disclosure of a trade secret (as that term is defined under applicable law) that: (A) is made in confidence to a Federal, State, or local government official, either directly or indirectly, or to an attorney, where such disclosure is made solely for the purpose of reporting or investigating a suspected violation of law; or (B) is made in a complaint or other document filed in a lawsuit or other proceeding, if such filing is made under seal.  If the Optionee files a lawsuit for reporting a suspected violation of the law, the Optionee may disclose the trade secret to the Optionee’s attorney and use the trade secret in the court proceeding if the Optionee files any document containing the trade secret under seal and does not disclose the trade secret except pursuant to court order.

b.    Non-Competition.  In consideration for (i) this Agreement and the benefits provided herein; (ii) the Company’s promise to provide Confidential Information to the Optionee, (iii) the substantial economic investment made by the Company in the Confidential Information and the goodwill of the Company, (iv) the Company’s employment of the Optionee, and (v) the compensation and other benefits provided by the Company to the Optionee, to protect the Company’s Confidential Information and the business goodwill of the Company, the Optionee agrees to the following restrictive covenants and the covenants set forth in Sections 14(c), (d), (e), and (f).  During the Optionee’s employment and for a twelve (12) month period subsequent to the date of the Optionee’s termination of employment (the “Restricted Period”), the Optionee agrees he or she will not, directly or indirectly, absent the express, written consent of the Chief Executive Officer of the Company (the “CEO”) or the Chairman of the Committee (the “Chairman”), or either of their respective designees, become or serve as, directly or indirectly, a director, officer, employee, owner, partner, advisor, agent, or consultant with, or engage in, any business that manufactures, provides or sells rail manufacturing, rail maintenance, rail leasing or rail management, tank or freight railcars, railcar parts or heads, or highway products, shipper services, and all other products and services provided, or seriously pursued, by the Company or its Affiliates during the period from the Date of Grant through the date of the Optionee’s termination of employment, in any state, or similar geographic territory, in which the Company or any of its Affiliates operate as of the date of the Optionee’s termination of employment and for which the Optionee performed services, had responsibility or received Confidential Information (“Restricted Territory”).  Further, for a twelve (12) month period after the Optionee’s termination of employment, the Optionee agrees not to serve as a consulting or testifying expert for any third party in any legal proceedings (including arbitration or mediation) or threatened legal proceedings involving the Company, unless called to do so by the Company or an Affiliate.  The Optionee agrees to notify the CEO in writing, with a copy of such notice to the Chairman, in the event the Optionee accepts employment or service of any nature with any person, business, or entity during the Restricted Period.
c.    Non-Solicitation. During the Restricted Period, other than in connection with the Optionee’s duties for the Company, the Optionee shall not, and shall not use any Confidential Information to, directly or indirectly, either as a principal, manager, agent, employee, consultant, officer, director, stockholder, partner, investor or lender or in any other capacity, and whether personally or through other persons, (i) solicit business, or attempt to solicit business, from any Client or Prospective Client, (ii) interfere with, or attempt to interfere with, the Company’s relationship, contracts or business with any Client or Prospective Client or Supplier, or (iii) induce or persuade in any manner, or attempt to induce or persuade, any Client or Prospective Client or Supplier to curtail or cancel any business or contracts with the Company.  This restriction applies only to business which is in the scope of services or products provided by the Company.  “Client or Prospective Client” means any client or prospective client with whom the Company did business or who the Company solicited within the twenty-four (24) month period preceding the Optionee’s termination of employment, and who or which: (A) the Optionee contacted, called on, serviced or did business with during the Optionee’s employment with the Company; (B) the Optionee learned of as a result of the Optionee’s employment with the Company; or (C) about whom the Optionee received Confidential Information.  “Supplier” means any person or entity that provided goods or services to the Company at any time during the two (2) year period before the Optionee’s termination of employment.
d.    Non-Recruitment.  During the Restricted Period, other than in connection with the Optionee’s duties for the Company, the Optionee shall not, and shall not use any Confidential Information to, on behalf of the Optionee or on behalf of any other person or entity, directly or indirectly, hire, solicit, induce, recruit, engage, go into business with, or attempt to hire, solicit, induce, recruit, engage, go into business with, or encourage to leave or otherwise cease his/her employment with the Company, any individual who is an employee or independent contractor of the Company or who was an employee or independent contractor of the Company within the twelve (12) month period prior to the Optionee’s termination of employment.

e.    Non-Disparagement.  The Optionee agrees that the Company’s goodwill and reputation are assets of great value to the Company which have been obtained and maintained through great costs, time and effort.  Therefore, during the Optionee’s employment and after the Optionee’s termination of employment for any reason, the Optionee shall not in any way disparage, libel or defame the Company, its business or business practices, its products or services, or its stockholders, managers, officers, directors, employees, investors or Affiliates.  Nothing in this Section 14(e) is intended to interfere with the Optionee’s right to engage in the conduct set forth in Section 14(a)(ii) or (iii). 
f.    Remedies.  By acceptance of this Agreement, the Optionee acknowledges that the geographic scope and duration of the restrictions and covenants contained in this Section 14 are fair and reasonable in light of (i) the nature and wide geographic scope of the operations of the Company’s business; (ii) the Optionee’s level of control over and contact with the business in the Restricted Territory; and (iii) the amount of compensation and Confidential Information that the Optionee is receiving in connection with the Optionee’s employment with the Company.  If the Optionee violates any of the restrictions contained in this Section 14, the Restricted Period shall be suspended and shall not run in favor of the Optionee until such time that the Optionee cures the violation to the satisfaction of the Company and the period of time in which the Optionee is in breach shall be added to the Restricted Period applicable to such covenant(s).  Further, by executing this Agreement, the Optionee acknowledges that the restrictions contained in this Section 14, in view of the nature of the Company’s businesses, are reasonable and necessary to protect their legitimate business interests, business goodwill and reputation, and that any violation of these restrictions would result in irreparable injury and continuing damage to the Company.  Accordingly, by executing this Agreement, the Optionee acknowledges and agrees that, in the event of the Optionee’s breach or threatened breach of the provisions in this Section 14, the Company shall be entitled to a temporary restraining order and injunctive relief restraining the Optionee from the commission of such breach or threatened breach, without the necessity of establishing irreparable harm or the posting of a bond, and to recover from the Optionee, damages incurred by the Company as a result of the breach, as well as the Company’s attorneys’ fees, costs and expenses related to such breach or threatened breach.  In addition, in the event the Optionee violates any of the restrictions contained in this Section 14, all benefits under this Agreement shall immediately cease, no additional Shares will be due to the Optionee pursuant to the Agreement and the Stock Option (whether vested or unvested) shall be terminated and forfeited, and, to the extent the Optionee has previously received Shares pursuant to this Agreement, upon written demand by the Company, the Optionee must immediately repay the Company the Shares previously received (or the value thereof as of such date, if the Shares have been sold or otherwise disposed of by the Optionee).  Nothing contained in this Agreement shall be construed as prohibiting the Company from pursuing any other remedies available to it for any breach or threatened breach, including, without limitation, the recovery of money damages, attorneys’ fees, and costs.  The existence of any claim or cause of action by the Optionee against the Company, whether predicated on this Agreement, the Plan or otherwise, shall not constitute a defense to the enforcement by the Company of the restrictive covenants contained in this Section 14, or preclude injunctive relief.
g.    Survival.  The provisions of this Section 14 shall survive any Termination of Service by the Optionee, the termination of the Stock Option, and/or the termination of this Agreement.
15.Entire Agreement; Modification.  This Agreement together with the Plan and the Notice of Grant supersede any and all other prior understandings, negotiations and agreements, either oral or in writing, between the parties with respect to the subject matter hereof and constitute the sole and only agreements between the parties with respect to the said subject matter.  The Optionee acknowledges that the Optionee is relying solely on the Optionee’s own judgment in entering into this Agreement, and not on any communications, promises, or representations of the Company or its agent, except as expressly contained in this Agreement.  The Committee may amend this Agreement or the Notice of Grant without the Optionee’s consent provided that it concludes that such amendment is not materially adverse to the Optionee, is permitted under Section 20 of the Plan, or is necessary for purposes of compliance with applicable law or compliance with or exemption from the requirements of Section 409A of the Code or any regulations or other guidance issued thereunder.  

Except as provided by the immediately preceding sentence, no change or modification of this Agreement or the Notice of Grant shall be valid or binding upon the parties unless the change or modification is in writing and signed by the parties.  Notwithstanding the preceding sentence, the Company may amend the Plan to the extent permitted by the Plan.

16.Law Governing.  The Notice of Grant and this Agreement shall be governed by, construed, and enforced in accordance with the laws of the State of Texas (excluding any conflict of laws rule or principle of Texas law that might refer the governance, construction, or interpretation of this Agreement to the laws of another state).

17.Repayment on Restatement. The Stock Option granted hereunder is subject to cancellation and any Shares deliverable upon exercise are subject forfeiture in order to satisfy amounts recoverable by the Company, upon a determination by the Committee pursuant to the Policy for Repayment on Restatement of Financial Statements in effect at the time of such determination, which Policy is incorporated herein by reference.

18.Notice.   Any notice required or permitted to be delivered hereunder shall be in writing and shall be deemed to be delivered only when actually received by the Company or the Optionee, as the case may be, at the addresses set forth below (or at such other addresses as they have theretofore specified by written notice delivered in accordance herewith):

a.    Notice to the Company shall be sent electronically to compensation@trin.net or in hard copy addressed and delivered as follows: Trinity Industries, Inc., 2525 Stemmons Freeway, Dallas, Texas 75207, Attention: Corporate Compensation Department.
b.    Notice to the Optionee shall be sent electronically to the Optionee’s Company e-mail address or, in hard copy addressed and delivered to the Optionee’s address then on file with the Company.
19.Acceptance.  The grant of the Stock Option is subject to and conditioned upon the Optionee’s electronic acceptance of the terms hereof.

* * * * * * * *Exhibit

Exhibit 10.1
November 6, 2018
Dear Girish:
This letter agreement ("Agreement") sets forth the terms and conditions of your offer of employment with Genocea Biosciences, Inc. (the "Company"). If accepted, the terms hereof shall be effective, and your employment shall commence on December 6, 2018 (the "Effective  Date").
1.Position and Duties. You shall serve, on a full-time basis, as the Company's Chief Business Officer, reporting directly to the Company's Chief Executive Officer. You agree that while employed by the Company you shall devote your full business time and professional efforts to the performance of your duties and responsibilities to the Company; abide by all Company policies and procedures as in effect from time to time; perform all of the customary duties of your position, which will include, but not be limited to, overseeing the Company's Business Development activities at all times with the highest legal, ethical and professional standards.
2.Compensation and Benefits. During your employment, as compensation for all services performed by you for the Company and subject to the performance of your duties and responsibilities to the Company pursuant to this Agreement or otherwise, the Company will provide you with the following compensation and benefits:
(a).Base Salary. The Company shall pay you a Base Salary at the rate of $385,000 per year in accordance with the Company's standard payroll practices, as in effect from time to time but at least on a semi-monthly basis ("Base Salary"). The Company shall review your Base Salary on an annual basis for upward adjustment. Any adjustments will be determined by the Company, in its sole discretion.
(b).Annual Bonus Compensation. Beginning for the calendar year 2019, you will be eligible to receive a performance-based annual bonus with a target of 40% of your Base Salary in effect as of December 31 of the previous calendar year (the "Target Bonus"). Your annual bonus, if any, for any year will be determined by the Board of Directors of the Company (the "Board") or the Compensation Committee of the Board (the "Committee") in accordance with the Company's annual bonus plan as in effect from time to time and will be based on performance criteria established by the Board or the Committee and disclosed to you within sixty (60) days of the beginning of each calendar year Any bonus due to you hereunder will be paid not later than March 15th of the year following the year to which the bonus relates. In the event

1

you are otherwise eligible to receive a Target Bonus and the Company terminates your employment without Cause or you terminate your employment for Good Reason (as defined below) following the conclusion of given calendar year, you will receive your full Target Bonus for that year and receive a pro-rated Target Bonus for the year (to be paid the subsequent year in accordance with the Company's payment practices) in which your termination or resignation occurs based upon the number of days worked in such year. In the event your employment is terminated for Cause or you resign without Good Reason, you will not receive any Target Bonus from the Company. The foregoing shall be construed and applied so that any bonus payable to you hereunder qualifies as a "short-tern deferral" under Section 409A.
(c).Signing Bonus. The Company shall pay you a cash signing bonus in the amount of $150,000 (the "Signing Bonus") payable on the first eligible payroll date in January 2019. In the event you receive the Signing Bonus but voluntarily terminate your employment without Good Reason (as defined below) within twelve months after the Effective Date, then you shall pay back to the Company a pro-rated portion of the Signing Bonus based upon the number of days remaining in this twelve-month period prior to termination of employment. You must pay this pro-rated portion to the Company within 30 days of the date of such termination of employment. You will not be required to repay the Signing Bonus in the event of termination of employment under any other circumstances.
(d).Stock Option Award. Subject to approval by the Board, at the first regularly scheduled meeting of the Board following the Effective Date, you will be eligible to receive a stock option award under the Company's equity plan then in effect with respect to 650,000 shares of common stock of the Company ("Common Stock"), with an exercise price that is no less than the fair market value of a share of Common Stock on the date of grant. To be eligible to receive this stock option award, you must be employed by the Company on the date the award is granted. The stock option award will be subject to the terms of the Company's equity plan under which it is granted and the terms of the award agreement evidencing such stock option.
(e).Benefits. As an employee, you will also be eligible to participate in the Company's standard employee benefit plans and programs as in effect from time to time for employees of the Company generally, except to the extent such plans or programs are duplicative of benefits otherwise provided to you under this Agreement (e.g., severance pay) or under any other agreement. Your participation in such plans or programs will be subject to the terms of the applicable plan documents and generally applicable Company policies.
(f).Vacation. You will be entitled to four (4) weeks of paid vacation, to be taken at such time or times as the needs of the Company's business reasonably permit and in accordance with the Company's policies from time to time in effect. You will be allowed to carry over one week of unused vacation from one year to the next.
(g).Insurance. You shall be entitled to liability insurance coverage on the same basis as other officers of the Company as to your acts or omissions to act during your employment with the Company as a manager or officer of the Company.,

2

3.Confidential Information and Invention Assignment Agreement. As a condition of your employment, you will be required to enter into a Confidential Information and Invention Assignment Agreement with the Company (the "Restricted Activities Agreement"), which will require, among other provisions, the assignment of patent rights to any invention made during your employment with the Company and nondisclosure of Company proprietary information. Your employment with the Company and the receipt of any severance payments or benefits under Section 5 of this Agreement are each conditioned upon and subject to your compliance with the Restricted Activities Agreement.
4.Termination of Employment. Your employment under this Agreement shall continue until terminated pursuant to this Section 4.
(a). Termination for Cause. The Company may terminate your employment for Cause, as defined below, upon written notice to you setting forth in reasonable detail the nature of the Cause. The following, as determined by the Board in its reasonable judgment, shall constitute "Cause" for termination:
(i).    the indictment or conviction for, any felony or any other crime involving
dishonesty;
(ii).participation in any fraud, deliberate and substantial misconduct, breach of duty of loyalty or breach of fiduciary duty against the Company or any Affiliate;
(iii).intentional and material damage to any property of the Company or any Affiliate;
(iv).serious and intentional or willful misconduct against the Company or any of its employees; or
(v).your breach of any material provision of this Agreement or the Restricted Activities Agreement.
Termination of your employment by the Company for Cause will result in no severance pay or severance benefits. In the case of termination for Cause under Section 4(a)(iii) or 4(a)(v), the Company will notify you of the conditions for such termination no later than 30 days following the occurrence of the condition and shall provide you with 10 days to remedy the condition in the event such condition is curable.
(a).Termination without Cause. The Company may terminate your employment at any time other than for Cause upon 14 days' written notice to you.
(b)Termination for Good Reason. You may terminate your employment hereunder for Good Reason, as defined below, by providing written notice to the Company of the condition giving rise to the Good Reason, specifying in detail the basis for such claim of Good Reason, no later than 30 days following the occurrence of the condition, by giving the Company 30 days to remedy the condition and by terminating employment for Good Reason 

3

within 30 days thereafter if the Company fails to remedy the condition. The following, if occurring without your consent, shall constitute "Good Reason" for termination by you:
(i).material diminution of your duties to the Company;
(ii).a material reduction in your Base Salary, or Target Bonus percentage of 40% (with materiality being defined for purposes of this subsection as five percent (5%) or more of the existing salary or Target Bonus percentage);
(iii).the failure of the Company to pay or to provide any of the compensation or benefits (including without limitation the compensation and benefits set forth in Section 2 of this Agreement) when due; for the avoidance of doubt, you understand that a good faith change in the Company's standard benefit plans and programs will not been deemed to constitute "Good Reason";
(iv).any directive given to you by the Company in violation of any law, regulation or Company policy; 
(v).a breach by the Company of a material provision of this Agreement; or
(vi).a change in the principal location at which you provide services to the Company beyond fifty (50) miles from Cambridge, Massachusetts.
(c).Termination without Good Reason. You may terminate your employment with the Company other than for Good Reason at any time upon 30 days' written notice to the Company.
(d).Termination Due to Death or Disability. This Agreement shall automatically terminate in the event of your death during employment. The Company may also terminate your employment, upon notice to you, in the event you become disabled during employment. For purposes of this Agreement, Disability is defined as any illness, accident, injury or condition of either a physical or psychological nature the onset of which renders you unable to continue to perform substantially all of your duties and responsibilities under this Agreement (notwithstanding the provision of any reasonable accommodation) for 180 days (whether or not consecutive) during any period of 365 consecutive calendar days. If any question shall arise as to whether you are disabled to the extent that you are unable to perform substantially all of your duties and responsibilities for the Company and its Affiliates, you shall, at the Company's request and expense, submit to a medical examination by a physician selected by the Company and such determination shall, for the purposes of this Agreement, be conclusive of the issue. If such a question arises and you fail to submit to the requested medical examination, the Company's determination of the issue shall be binding on you.
5.    Severance and other Matters Related to Termination.

4

(a). Termination by the Company without Cause or by you for Good Reason. Subject to Section 5(b), Section 5(f) and Section 11, in the event that your employment is terminated by the Company without Cause pursuant to Section 4(b) or by you for Good Reason pursuant to Section 4(b), in addition to the Accrued Compensation (as defined below), which shall be paid at the time provided in Section 5(d) below, you shall be entitled to the severance payments and benefits specified below.
(i).    the Company shall continue to pay you your Base Salary, at the rate then in effect, for the 9-month period following the date on which your employment with the
Company terminates in accordance with the Company's standard payroll policy as then in effect and shall pay you the Target Bonus as further detailed in Section 2(b) above; and
(ii).    subject to your timely election to continue participation in the Company's group health and dental plans under COBRA, and only for so long as you are eligible for such coverage through COBRA, the Company shall pay you, on a monthly and taxable basis, an amount equal to the full monthly premium cost of such participation until the conclusion of the nine-month period following the date on which your employment with the Company terminates, or, if earlier, until the date you become eligible to enroll in such plans of any new employer.
(b). Termination by the Company without Cause or by you for Good Reason in connection with a Change of Control. Subject to Section 5(f), and Section 11, in the event that your employment is terminated by the Company without Cause pursuant to Section 4(b) or by you for Good Reason pursuant to Section 4(b), in either case, within 12 months following a Change of Control, in addition to the Accrued Compensation (as defined below), which shall be paid at the time specified in Section 5(d) below, in lieu of any payments and benefits provided in Section 5(a) above, you shall be entitled to the severance payments and benefits specified below:
(i).the Company shall continue to pay you your Base Salary, at the rate then in effect, for the 15-month period following the date on which your employment with the Company terminates in accordance with the Company's standard payroll policy as then in effect;
(ii).subject to your timely election to continue participation in the Company's group health and dental plans under COBRA, and only for so long as you are eligible for such coverage through COBRA, the Company shall pay you, on a monthly and taxable basis, an amount equal to the full monthly premium cost of such participation until the conclusion of the 15-month period following the date on which your employment with the Company terminates, or, if earlier, until the date you become eligible to enroll in such plans of any new employer; and
(iii).all outstanding and unvested stock options and other equity awards then held by you will become fully vested and exercisable and, with respect to any stock options 

5

then held by you, shall remain exercisable for the period of time set forth in the applicable grant agreement.
(c).    Termination by the Company due to your Disability or due to your Death. Subject to Section 5(f) and Section 11, in the event your employment with the Company is terminated by the Company due to your Disability (as defined above) or is terminated due to your death, in either case, pursuant to Section 4(e), in addition to the Accrued Compensation (as defined below), which shall be paid at the time specified in Section 5(d), the Company shall pay you at the same time as the Accrued Compensation is paid a pro-rata annual bonus for the year in which such termination of employment occurs, calculated by multiplying your target annual bonus for such year by a fraction, the numerator of which is the number of days you were employed during such year and the denominator of which is 365 (the "Pro-Rata Bonus").
(d). Any Termination. In the event your employment with the Company terminates for any reason, in addition to the compensation set forth above in connection with a termination without Cause or for Good Reason, you will remain entitled to, and will be paid, any Target Bonus payment due under Section 2(b) and not paid at the time of termination, and the Company shall also pay you on the first payroll date that follows the date of the termination of your employment (or on such earlier date as is required by law) the Accrued Compensation. For purposes of this Agreement, "Accrued Compensation" means any Base Salary earned but not paid through the date of the termination of employment and an amount equal to the value of any vacation time accrued but unused as of such date.
(e).    Parachute Payments.
(i).In the event of the consummation of a change in ownership or control within the meaning of Section 280G (a "280G Change in Control") of the Company following the time that the Company has stock readily tradeable on an established securities market (within the meaning of Section 280G and the regulations thereunder), if all or a portion of the payments and benefits under this Agreement, together with any other payments and benefits provided to you by the Company or its Affiliates (including, without limitation, any accelerated vesting of stock options and other equity awards) (the "Total Payments"), would constitute an "excess parachute payment" within the meaning of Section 280G (the aggregate of such payments (or portions thereof) being hereinafter referred to as the "Excess Parachute Payments"), you will be entitled to receive (A) an amount limited so that no portion thereof shall fail to be tax deductible under Section 280G (the "Limited Amount"), or (B) if the amount otherwise payable hereunder or otherwise (without regard to clause (A)) reduced by all taxes applicable thereto (including, for the avoidance of doubt, the excise tax levied under Section 4999 of the Code (the "Excise Tax")) would be greater than the Limited Amount reduced by all taxes applicable thereto, the amount otherwise payable hereunder or otherwise.
(ii).The determination as to whether the Total Payments include Excess Parachute Payments and, if so, the amount of such Excess Parachute Payments, the amount of any Excise Tax with respect thereto, and the amount of any reduction in Total Payments shall 

6

be made at the Company's expense by the independent public accounting firm most recently serving as the Company's outside auditors or such other accounting or benefits consulting group or firm as the Company may designate (the "Accountants"). In the event that any payments under this Agreement or otherwise are required to be reduced as described in Section 5(e)(i), the adjustment will be made, first, by reducing the amount of Base Salary payable pursuant to Section 5(a)(i) or Section 5(b)(i), as applicable; second, if additional reductions are necessary, by reducing the payment of the amounts due to you pursuant to Section 5(a)(ii) or Section 5(b)(ii), as applicable; and third, if additional reductions are still necessary, by eliminating the accelerated vesting of stock option awards and other equity awards, if any, starting with those awards for which the amount required to be taken into account under Section 280G is the greatest.
(iii).In the event that there has been an underpayment or overpayment under this Agreement or otherwise as determined by the Accountants, the amount of such underpayment or overpayment shall forthwith be paid to you or refunded to the Company, as the case may be, with interest at the applicable federal rate provided for in Section 7872(f)(2) of the Code.
(f).    Release. Any obligation of the Company to provide you severance payments or other benefits (including accelerated vesting of stock options and other equity awards) or any Pro-Rata Bonus under this Section 5 (for the avoidance of doubt, other than Accrued Compensation), is conditioned on your (or your legal representative, if applicable, in the case of a termination due to your death or disability pursuant to Section 4(e)) signing a release of claims in the form provided by the Company (the "Release") following the termination of your employment within a period of time not to exceed 45 days from the date of your receipt of such Release, and on your (or your legal representative, if applicable) not revoking the Release within the revocation period provided therein following your (or your legal representative's, if applicable) execution of the Release, which release shall not apply to (i) any payments due under this Agreement that survive termination of employment, (ii) claims for indemnification in your capacity as an officer or director of the Company under the Company's Certificate of Incorporation, Bylaws or written agreement, if any, providing for director or officer indemnification, (iii) rights to receive insurance payments under any policy maintained by the Company, (iv) rights under any stock option or equity agreements that remain vested or exercisable after termination and (v) rights to receive retirement benefits that are accrued and fully vested at the time of your termination. Except as otherwise provided in Section 11 of this Agreement, any payments to be made in the form of salary continuation pursuant to the terms of this Agreement shall be payable in accordance with the normal payroll practices of the Company, with the first such payment (which shall be retroactive to the day immediately following the date of your termination of employment) due and payable as soon as administratively practicable following the date the Release becomes effective, but not later than the date that is 60 days following the date your employment terminates. Notwithstanding the foregoing, if the date your employment terminates occurs in one taxable year and the date that is 60 days following such termination date occurs in a second taxable year, to the extent 

7

required by Section 409A, such first payment shall not be made prior to the first day of the second taxable year. For the avoidance of doubt, if you (or your legal representative, if applicable) do not execute an Release within the period specified in this Section 5(f), or if you (or your legal representative, if applicable) revoke the executed Release within the time period permitted by law, you will not be entitled to any payments or benefits (including the accelerated vesting of stock options or other equity awards) or any Pro-Rata Bonus set forth in this Section 5 (other than the Accrued Compensation), any stock options and other equity awards that vested on account of such termination as provided for in this Agreement shall be cancelled with no consideration due to you, and neither the Company nor any of its Affiliates will have any further obligations to you under this Agreement or otherwise. You agree to provide the Company prompt notice of your eligibility to participate in the health and, if applicable, dental, plan of any employer. You further agree to repay any overpayment of health and, if applicable, dental, benefit premiums made by the Company hereunder. Notwithstanding anything to the contrary herein, in the event that the Company's payment of the amounts described in Section 5(a)(ii) or Section 5(b)(ii), as applicable, would subject the Company to any tax or penalty under the Patient Protection and Affordable Care Act (as amended from time to time, the "ACA") or Section 105(h) of the Internal Revenue Code of 1986, as amended ("Section 105(h)"), or applicable regulations or guidance issued under the ACA or Section 105(h), you and the Company agree to work together in good faith to restructure such benefit.
(g).    Survival, Conditions to Severance. Provisions of this Agreement shall survive
any termination if so provided in this Agreement or if necessary or desirable to accomplish the purposes of other surviving provisions, including without limitation your obligations under Section 3 of this Agreement and under the Restricted Activities Agreement and the Nondisclosure Agreement. The obligation of the Company to make payments to you or on your behalf under Section 5 of this Agreement is expressly conditioned upon (i) your full performance of your obligations under Section 3 hereof pursuant to the Restricted Activities Agreement and the Nondisclosure Agreement and under any subsequent agreement between you and the Company or any of its Affiliates relating to confidentiality, non-competition, proprietary information or the like, and (ii) your (or your legal representative's, if applicable, in the case of a termination due to your death or disability pursuant to Section 4(e)) timely execution and non-revocation of the Release as set forth in Section 5(f).
6.    Definitions. For purposes of this Agreement, the following definitions apply:
(a)."Affiliates" means all persons and entities directly or indirectly controlling, controlled by or under common control with the Company, where control may be by management authority, equity interest or otherwise.
(b)."Change of Control" means the first to occur of any of the following: (i) a merger or consolidation in which (A) the Company is a constituent party, or (B) a subsidiary of the Company is a constituent party and the Company issues shares of its capital stock pursuant to such merger or consolidation, except in the case of either clause (A) or (B) any such merger or 

8

consolidation involving the Company or a subsidiary of the Company in which the beneficial owners of the shares of capital stock of the Company outstanding immediately prior to such merger or consolidation continue beneficially to own, immediately following such merger or consolidation, at least a majority by voting power of the capital stock of (x) the surviving or resulting corporation or (y) if the surviving or resulting corporation is a wholly owned subsidiary of another corporation immediately following such merger or consolidation, the parent corporation of such surviving or resulting corporation; (ii) the sale, lease, transfer, exclusive license or other disposition, in a single transaction or series of related transactions, by the Company or a Company subsidiary of all or substantially all the assets of the Company and the Company subsidiaries taken as a whole (except in connection with a merger or consolidation not constituting a Change of Control under clause (i) or where such sale, lease, transfer, exclusive license or other disposition is to a wholly owned Company subsidiary); or (iii) the sale or transfer, in a single transaction or series of related transactions, by the stockholders of the Company of more than 50% by voting power of the then-outstanding capital stock of the Company to any Person or entity or group of affiliated Persons or entities.
(c)."Code" means the Internal Revenue Code of 1986, as amended.
(d)."Person" means an individual, a corporation, an association, a partnership, an estate, a trust and any other entity or organization, other than the Company or any of its Affiliates.
(e)."Section 280G" means Section 280G of the Code, together with the regulations thereunder.
(f)."Section 409A" means Section 409A of the Code, together with the regulations thereunder.
7.    Conflicting Agreements. You hereby represent and warrant that your signing of this Agreement and the performance of your obligations under it will not breach or be in conflict with any other agreement to which you are a party or are bound and that you are not now subject to any covenants against competition or similar covenants or any court order that could affect the performance of your obligations under this Agreement. You agree that, during the term of your employment with the Company, you will not engage in any other employment, occupation, consulting or other business activity directly related to the business in which the Company is now involved or becomes involved during the term of your employment, nor will you engage in any other activities that conflict with your obligations to the Company. Notwithstanding the foregoing, nothing in this Agreement shall prevent you from serving as an advisor or director for any for-profit businesses or non-profit organization or serving in various other capacities in community, civic, religious, charitable or trade organizations, provided that such participation does not, individually or in the aggregate, materially interfere or conflict with the performance of your duties hereunder. You further agree not to disclose or use on behalf of the Company any proprietary or confidential information of a third party, including that of any former employer, without such third party's consent.

9

8.Withholding; Other Tax Matters. Anything to the contrary notwithstanding, all payments required to be made by the Company hereunder to you shall be subject to the withholding of such amounts, if any, relating to tax and other payroll deductions as the Company may determine it should withhold pursuant to any applicable law or regulation.
9.Assignment. Neither you nor the Company may make any assignment of this Agreement or any interest in it, by operation of law or otherwise, without the prior written consent of the other; provided, however, that the Company may assign its rights and obligations under this Agreement without your consent to one of its Affiliates or to any Person with or into which the Company hereafter affects a reorganization, consolidates or merges, or to which it transfers all or substantially all of its properties or assets. This Agreement shall inure to the benefit of and be binding upon you and the Company and each of its respective successors, executors, administrators, heirs and permitted assigns.
10.Severability. If any portion or provision of this Agreement shall to any extent be declared illegal or unenforceable by a court of competent jurisdiction, then the remainder of this Agreement, or the application of such portion or provision in circumstances other than those as to which it is so declared illegal or unenforceable, shall not be affected thereby, and each portion and provision of this Agreement shall be valid and enforceable to the fullest extent permitted by law.
11.Section 409A.
(a).You and the Company agree that this Agreement shall be interpreted to comply with or be exempt from Section 409A, and the regulations and guidance promulgated thereunder to the extent applicable, and all provisions of this Agreement shall be construed in a manner consistent with the requirements for avoiding taxes or penalties under Section 409A.
(b).A termination of employment shall not be deemed to have occurred for purposes of any provision of this Agreement providing for the payment of any amounts or benefits considered "nonqualified deferred compensation" under Section 409A upon or following a termination of employment unless such termination is also a "separation from service" within the meaning of Section 409A (after giving effect to the presumptions contained therein) and, for purposes of any such provision of this Agreement, references to a "termination", "termination of employment" or like terms shall mean "separation from service". If you are deemed on the date of termination to be a "specified employee" within the meaning of that term under Section 409A(a)(2)(B), then with regard to any payment or the provision of any benefit that is considered nonqualified deferred compensation under Section 409A payable on account of a "separation from service", such payment or benefit shall be made or provided at the date which is the earlier of (a) the expiration of the six-month period measured from the date of such "separation from service", and (b) the date of your death (the "Delay Period"). Upon the expiration of the Delay Period, all payments and benefits delayed pursuant to this Section 11(b) (whether they would have otherwise been payable in a single sum or in installments in the absence of such delay) shall be paid or reimbursed on the first business day following the expiration of the Delay Period to you 

10

in a lump sum, and any remaining payments and benefits due under this Agreement shall be paid or provided in accordance with the normal payment dates specified for them herein.
(c).With regard to any provision herein that provides for payment or reimbursement of costs and expenses or in-kind benefits, except as permitted by Section 409A, (a) the right to payment, reimbursement or in-kind benefits shall not be subject to liquidation or exchange for another benefit; (b) the amount of expenses eligible for payment or reimbursement, or in-kind benefits, provided during any taxable year shall not affect the expenses eligible for payment or reimbursement, or in-kind benefits, to be provided in any other taxable year; and (c) such payments shall be made on or before the last day of your taxable year following the taxable year in which the expense occurred.
(d).For purposes of Section 409A, your right to receive any installment payments pursuant to this Agreement shall be treated as a right to receive a series of separate and distinct payments.
(e).In no event shall the Company or any of its Affiliates have any liability relating to the failure or alleged failure of any payment or benefit under this Agreement to comply with, or be exempt from, the requirements of Section 409A.
12.Entire Agreement. This Agreement, together with the Restricted Activities Agreement and the Nondisclosure Agreement, sets forth the entire agreement between you and the Company and replaces and supersedes all prior communications, agreements and understandings, written or oral, with respect to the terms and conditions of your employment.
13.Amendment. This Agreement may not be modified or amended, and no breach shall be deemed to be waived, except by a written agreement signed by an authorized representative of the Company and you.
14.Miscellaneous. The headings and captions in this Agreement are for convenience only and in no way define or describe the scope or content of any provision of this Agreement. This Agreement may be executed in two or more counterparts, each of which shall be an original and all of which together shall constitute one and the same instrument. This is a Massachusetts contract and shall be governed and construed in accordance with the laws of the Commonwealth of Massachusetts, without regard to the conflict-of-laws principles thereof.
15.Notices. Any notices provided for in this Agreement shall be in writing and shall be effective when delivered in person, consigned to a reputable national courier service for overnight delivery or deposited in the United States mail, postage prepaid, and addressed to you at your last known address on the books of the Company or, in the case of the Company, to it by notice to the Chief Executive Officer, c/o Genocea Biosciences, Inc. at its principal place of business.
16.At-Will Employment. The Company is excited about your employment and looks forward to a mutually beneficial and productive relationship. Nevertheless, you should be 

11

aware that your employment with the Company is for no specified period, and constitutes at-will employment. You are free to resign at any time, for any reason or for no reason. Similarly, the Company is free to conclude its employment relationship with you at any time, with or without Cause, and with or without notice. Further, the Immigration Reform and Control Act requires the Company to verify your identity and employment eligibility within three business days of the Effective Date. Your employment is conditioned on your timely completion of a Form 1-9 and provision of the appropriate documents listed on that form.
If the foregoing is acceptable to you, please sign and date this letter in the spaces provided. If you sign and return this letter, this letter will take effect as a binding agreement between you and the Company on the basis set forth above and the terms hereof will be effective on the Effective Date. If you do not commence employment on the Effective Date, this letter shall terminate and be of no force and effect, without further action by the parties hereto, and you shall not be entitled to any of the compensation or benefits provided hereunder. The enclosed copy is for your records.
Sincerely,

/s/ William Clark
Name: William Clark
Title: President and Chief Executive Officer

Agreed to and accepted,

Signature: /s/ Girish Aakalu
Printed Name: Girish Aakalu, PhD
Date: 11/12/2018 

12

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00308-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00308-of-00352.parquet"}]]